Skip to main content

Baxter International Inc.

corporate_fare Company Profile

Baxter International Inc.

BAX·NYSE·Industrial Applications And Services·CIK 0000010456

Baxter International Inc., through its subsidiaries, provides a wide range of essential healthcare products. These include sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. These products are utilized in various healthcare settings such as hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and by patients at home under physician supervision. The company's global presence and the critical nature of its products and services are important for expanding access to healthcare in both emerging and developed countries. As of December 31, 2025, following the sale of its Kidney Care business, Baxter International Inc. manufactured products in over 20 countries and sold them in over 100 countries. The company was incorporated under Delaware law in 1931. Since January 2023, Baxter International Inc. has undertaken several strategic actions, including the sale of its Kidney Care business. On August 12, 2024, the company entered into an Equity Purchase Agreement with affiliates of Carlyle Group Inc. to sell its Kidney Care business, now known as Vantive Health LLC. The sale was completed on January 31, 2025, for an aggregate purchase price of $3.80 billion in cash, subject to certain adjustments. After these adjustments, the company received approximately $3.71 billion in pre-tax cash proceeds at closing, with net after-tax proceeds of approximately $3.3 billion, before certain post-closing adjustments.

Baxter International Inc. (NYSE:BAX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 25 items for BAX at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • CFO Joel Grade Departs; Anita Zielinski Named Interim CFO as Company Reaffirms 2026 Outlook
  • Baxter Seeks Shareholder Approval for 20M New Incentive Shares and Executive Compensation Amidst Turnaround
  • Baxter Slashes Oil-Price Exposure by Over 50%, Significantly Reducing Commodity and Geographic Risk
  • Baxter Reports Significant Net Loss, Major Impairments, Product Recalls, and Legal Challenges in 2025 Annual Report
  • Baxter Reports Q4 Miss, Weak 2026 Outlook, Slashes Dividend to $0.01, and Announces Board Changes

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.24B
Net Income
-$957M
Diluted EPS
-$1.87
Op. Cash Flow
$845M
Free Cash Flow
$332M
Gross Profit
$3.38B
Operating Income
-$308M
Cash & Equivalents
$1.97B
Total Debt
$1M
Debt / Equity
0.00×
Net Margin
-8.5%
Shares Outstanding
513M sh
Source: 10-K · filed 2026-02-12 · accession 0001628280-26-007733
$25.43 +0.16% today
52-week range · as of 2026-10-29 $15.73 – $30
Market cap
$13.14B
Volume
4.3M (0.7× avg)
3-mo avg 6.5M
Live data · 2026-11-22 10:00 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BAX - Filings & News (Page 2)

BAX
Mar 16, 2026, 8:49 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.52
Real-time Price: $25.43 info
Change: +$7.91 (+45%) info
Market Cap: $13.135B info
BAX
Mar 13, 2026, 8:48 AM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $18.00
Real-time Price: $25.43 info
Change: +$7.43 (+41%) info
Market Cap: $13.135B info
BAX
Mar 11, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $18.15
Real-time Price: $25.43 info
Change: +$7.28 (+40%) info
Market Cap: $13.135B info
BAX
Feb 12, 2026, 4:46 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $18.66
Real-time Price: $25.43 info
Change: +$6.77 (+36%) info
Market Cap: $13.135B info
BAX
Feb 12, 2026, 7:17 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $19.10
Real-time Price: $25.43 info
Change: +$6.33 (+33%) info
Market Cap: $13.135B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets